ENTITY
Genomma Lab Internacional Sab

Genomma Lab Internacional Sab (LABB MM)

16
Analysis
Health Care • Mexico
Genomma Lab Internacional SAB de CV develops, markets, sells and distributes over-the-counter drugs and personal care products.
more
bullish•Macroeconomics
•07 Aug 2025 04:51•Syndicated

Actinver Research - Consumer Post 2Q25 Update

On average, our covered Consumer companies grew top line by 8% YoY (vs. 7% forecasted), and EBITDA by 5% (vs. our 3% estimate).

Logo
Actinver
272 Views
Share
bullish•Macroeconomics
•13 May 2025 01:02•Syndicated

Actinver Research - Consumer Post 1Q25 Update

Soft consumer environment, with weaker conditions at the beginning of the year vs the company’s expectations; a warmer season didn’t help either.

Logo
Actinver
214 Views
Share
bearish•Angiodynamics Inc
•14 Jan 2025 06:15•Syndicated

Closing 5 ideas | Jan 13, 2025

I am taking several off the list, first one being Angiodynamics (ANGO) written up here . It jumped in the past week on a slightly improved forecast...

Share
•10 Dec 2024 23:00•Syndicated

Actinver Research - Genomma Lab: Reaching Healthier Valuation Levels (Company Update)

After a stunning YTD performance (up 90.68% as of 12/9/24 vs MEXBOL 9.05% down), we continue to see solid upside ahead. Market conditions for most...

Logo
Actinver
302 Views
Share
bullish•Macroeconomics
•04 Nov 2024 23:01•Syndicated

Actinver Research - Consumer post 3Q24: Sales deceleration while trying to protect margins

Having recently launched our Food & Bev coverage (link to report here), we reiterate our Outperform ratings in beverage companies AC (PT down to...

Logo
Actinver
237 Views
Share
x